查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1726234

外用藥物契約製造市場規模、佔有率、趨勢分析報告：按產品類型、業務規模、最終用途、地區和細分市場預測，2025 年至 2030 年

Topical Drugs Contract Manufacturing Market Size, Share & Trends Analysis Report By Product Type, By Scale Of Operation, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

外用藥物契約製造市場的成長與趨勢

根據 Grand View Research, Inc. 的一份新報告，預計到 2030 年全球外用藥物契約製造市場規模將達到 545.5 億美元。

預計 2025 年至 2030 年間，市場複合年成長率將達到 11.05%。目前，受不斷變化的治療需求、外包趨勢和技術進步的推動，全球外用藥物契約製造市場正在經歷顯著成長。此外，皮膚病患病率的不斷上升、老年人口的不斷成長，再加上人們對乳膏、凝膠、軟膏、噴霧劑和經皮吸收貼片非侵入性給藥方式的偏好，使得受託製造廠商（CMO）等外包服務對於最佳化成本、確保法規遵從性和提高生產能力至關重要。此外，CMO 還提供許多好處，有助於簡化業務、降低內部製造成本並加快產品上市時間，從而進一步促進市場擴張。此外，消費者對外用藥物的需求不斷成長，使得外包成為一項策略重點，特別是對於需要專業知識和適應性基礎設施的半固態和經皮製劑等產品線。

此外，成本動態在市場成長中發揮關鍵作用。根據定價分析，北美提供符合監管標準的高品質製造，而印度、中國和韓國等亞太國家則提供更具成本效益的製造選擇和不斷提高的產能。勞動力成本下降、政府支持政策以及符合良好生產規範 (GMP) 的市場的發展等因素正在推動亞太市場的發展。此外，連續製造、奈米膠囊化、先進均質化和 3D 列印等技術創新正在提高配方精度、生物有效性和批次一致性。這些進步正在幫助 CMO 應對複雜的產品需求並滿足消費者對功效和客製化日益成長的期望。

此外，定價模型正在透過將業務績效與財務結果相結合而不斷發展。然而，美國對進口活性藥物成分（API）和輔料徵收關稅等外部因素正在給供應鏈帶來成本壓力，尤其影響到出口商。儘管存在這些挑戰，但預計市場在預測期內仍將成長。同樣，策略舉措和加速產品發布正在推動市場發展。例如，2024年7月，Arcutis BIoTherapeutics, Inc.宣佈在美國推出ZORYVE Cream 0.15%，用於治療成人和6歲以下兒童的輕度至中度異位性皮膚炎。這種新型藥膏每天使用一次，不含類固醇，可快速緩解疼痛、減少搔癢，進而達到長期控制。預計此類技術創新將在預測期內進一步推動市場發展。

外用藥物契約製造市場報告重點

  • 半固態劑型佔市場主導地位，2024 年的佔有率為 65.54%。推動這一成長的因素包括皮膚病患病率的上升、患者對標靶治療的偏好、半固態劑型的便利性，以及治療和化妝品領域對改善藥物吸收、穩定性和美觀性的需求。
  • 根據業務規模，商業部門在 2024 年佔據了最大的市場佔有率。這些因素包括外包趨勢的上升、對皮膚病學和經皮治療的需求的增加、監管要求、成本效益以及需要專業製造技術的日益複雜的配方。
  • 到 2024 年，製藥公司將佔據最終用途最高的市場佔有率。由於對非侵入性治療、慢性皮膚病治療、提高患者依從性的需求不斷增加，以及美容皮膚科和先進的經皮給藥系統機會不斷增加，這些公司正在利用 CMO 服務。
  • 由於美國、加拿大等地受託製造廠商(CMO) 數量的增加，預計北美在預測期內的複合年成長率將達到 10.37%。此外，熟練勞動力的可用性和監管環境預計將顯著促進該地區市場的擴張。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章外用藥物契約製造市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/支持市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 定價模式分析
  • 科技
  • 市場分析工具
    • 波特五力分析
    • PESTEL 與 SWOT 分析
    • COVID-19影響分析

第4章：外用藥物契約製造市場：依產品類型估算與趨勢分析

  • 外用藥物契約製造市場（按產品類型）：細分儀表板
  • 外用藥物契約製造市場（依產品類型）：波動分析
  • 依產品類型，2018-2030
  • 半固態製劑
    • 奶油
    • 軟膏
    • 凝膠
    • 其他
  • 液體製劑
  • 固態製劑
  • 經皮產品

第5章：外用藥物契約製造市場：按業務規模進行的估計和趨勢分析

  • 外用藥物契約製造市場（按業務規模）：細分儀表板
  • 外用藥物契約製造市場（依企業規模）：波動分析
  • 按業務規模，2018-2030年
  • 臨床
  • 商業的

第6章：外用藥物契約製造市場：依最終用途的估計和趨勢分析

  • 局部用藥契約製造市場（依最終用途）：細分儀表板
  • 外用藥物契約製造市場（依最終用途）：波動分析
  • 依最終用途，2018-2030 年
  • 製藥公司
  • 生物製藥公司
  • 其他

第7章：外用藥物契約製造市場：按地區估計和趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 丹麥
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 泰國
    • 韓國
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭態勢

  • 市場參與企業分類
  • 2024 年公司市場佔有率/估值分析
  • 公司簡介
    • MedPharm
    • DPT Laboratories Ltd
    • Cambrex Corporation
    • Kindeva Drug Delivery
    • AbbVie Contract Manufacturing
    • NextPharma
    • Catalent Pharma Solutions
    • Thermo Fisher Scientific
    • Lonza Group
    • The Lubrizol Corporation
    • SGS SA
    • Bora Pharmaceutical CDMO
Product Code: GVR-4-68040-555-9

Topical Drugs Contract Manufacturing Market Growth & Trends:

The global topical drugs contract manufacturing market is expected to reach USD 54.55 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 11.05% from 2025 to 2030. Currently, the global market for contract manufacturing of topical drugs is currently experiencing significant growth, driven by evolving therapeutic needs, outsourcing trends, and advancements in technology. Moreover, with the increasing prevalence of dermatological conditions, coupled with a rising geriatric population and a preference for non-invasive drug delivery methods such as creams, gels, ointments, sprays, and transdermal patches has made outsourcing services like Contract Manufacturing Organizations (CMOs) essential for optimizing costs, ensuring regulatory compliance, and enhancing production capabilities. In addition, CMOs offer numerous advantages that support streamline operations, lower in-house manufacturing expenses, and speed up product commercialization, further contributing to market expansion. In addition, with the rising consumer demand for topical drugs, outsourcing has become a strategic priority, particularly for semi-solid and transdermal product lines that require specialized expertise and adaptable infrastructure.

Furthermore, cost dynamics play a crucial role in the growth of the market. Based on the pricing analysis, the North America provides high-quality manufacturing that complies with regulatory standards, while the Asia Pacific's countries like India, China, and South Korea offers more cost-effective production options with growing capabilities. Factors such as lower labor costs, supportive government policies, and a developing infrastructure complaint with Good Manufacturing Practices (GMP) are fueling the market in Asia Pacific. Furthermore, technological innovations such as continuous manufacturing, nanoencapsulation, advanced homogenization, and 3D printing are improving formulation accuracy, bioavailability, and batch consistency. These advancements support the CMOs to meet complex product demands and meet rising consumer expectations for efficacy and customization.

Furthermore, pricing models are evolving with aligning financial results with performance. However, external factors like U.S. tariffs on imported active pharmaceutical ingredients (APIs) and excipients have created cost pressures in the supply chain, particularly impacting exporters. Despite these challenges, the market is expected to witness growth during the forecast period. Likewise, strategic initiatives and accelerating product launches drive the market. For instance, in July 2024, Arcutis Biotherapeutics, Inc. announced the release of ZORYVE cream 0.15% for the treatment of mild to moderate atopic dermatitis in both adults and children under 6 in the U.S. This new cream, which is applied once daily and contains no steroids, provides quick relief from symptoms and reduces itching, allowing for better long-term management of the condition. Such innovations are expected to further propel the market during the forecast period.

Topical Drugs Contract Manufacturing Market Report Highlights:

  • The semi-solid formulations segment dominated the market, with a share of 65.54% in 2024. This growth is driven by the increasing prevalence of skin diseases, patient preferences for targeted therapies, the convenience of semi-solid formulations, and the demand for improved drug absorption, stability, and aesthetic appeal within both therapeutic and cosmetic sectors.
  • Based on the scale of operation, the commercial segment held the largest market share in 2024, attributed to the growing trend toward outsourcing, increased demand for dermatological and transdermal therapies, regulatory compliance, increased cost efficiency, and the rising complexity of formulations that require specialized manufacturing expertise.
  • The pharmaceutical companies segment held the largest market share in 2024 based on end-use. These companies leverage CMO services due to increasing demand for non-invasive therapies, treatments for chronic skin conditions, improved patient compliance, and opportunities within cosmetic dermatology and advanced transdermal drug delivery systems.
  • North America is expected to register a growth rate of 10.37% CAGR over the forecast period due to the rising number of contract manufacturing organizations(CMOs) in countries such as the U.S. and Canada. In addition, the availability of a skilled workforce and regulatory scenarios are expected to significantly contribute to the market's expansion in this region.

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product Type
    • 1.2.2. Scale of Operation
    • 1.2.3. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Parent Market Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Topical Drugs Contract Manufacturing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Pricing Model Analysis
  • 3.4. Technology Landscape
  • 3.5. Market Analysis Tools
    • 3.5.1. Porter's Five Force Analysis
    • 3.5.2. PESTEL by SWOT Analysis
    • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Topical Drugs Contract Manufacturing Market: Product Type Estimates & Trend Analysis

  • 4.1. Topical Drugs Contract Manufacturing Market, By Product Type: Segment Dashboard
  • 4.2. Topical Drugs Contract Manufacturing Market, By Product Type: Movement Analysis
  • 4.3. Topical Drugs Contract Manufacturing Market Estimates & Forecasts, By Product Type, 2018 - 2030
  • 4.4. Semi-Solid Formulations
    • 4.4.1. Semi-Solid Formulations Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Creams
      • 4.4.2.1. Creams Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Ointments
      • 4.4.3.1. Ointments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Gel
      • 4.4.4.1. Gel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Others
      • 4.4.5.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Liquid Formulations
    • 4.5.1. Liquid Formulations Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Solid Formulations
    • 4.6.1. Solid Formulations Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Transdermal Products
    • 4.7.1. Transdermal Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Topical Drugs Contract Manufacturing Market: Scale of Operation Estimates & Trend Analysis

  • 5.1. Topical Drugs Contract Manufacturing Market, By Scale of Operation: Segment Dashboard
  • 5.2. Topical Drugs Contract Manufacturing Market, By Scale of Operation: Movement Analysis
  • 5.3. Topical Drugs Contract Manufacturing Market Estimates & Forecasts, By Scale of Operation, 2018 - 2030
  • 5.4. Clinical
    • 5.4.1. Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Commercial
    • 5.5.1. Commercial Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Topical Drugs Contract Manufacturing Market: End Use Estimates & Trend Analysis

  • 6.1. Topical Drugs Contract Manufacturing Market, By End Use: Segment Dashboard
  • 6.2. Topical Drugs Contract Manufacturing Market, By End Use: Movement Analysis
  • 6.3. Topical Drugs Contract Manufacturing Market Estimates & Forecasts, By End Use, 2018 - 2030
  • 6.4. Pharmaceutical Companies
    • 6.4.1. Pharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Biopharmaceutical Companies
    • 6.5.1. Biopharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Topical Drugs Contract Manufacturing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. North America
    • 7.4.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. U.S
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Thailand
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Australia
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Company Market Share/Assessment Analysis, 2024
  • 8.3. Company Profiles
    • 8.3.1. MedPharm
      • 8.3.1.1. Company Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Service Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. DPT Laboratories Ltd
      • 8.3.2.1. Company Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Service Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Cambrex Corporation
      • 8.3.3.1. Company Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Service Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Kindeva Drug Delivery
      • 8.3.4.1. Company Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Service Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. AbbVie Contract Manufacturing
      • 8.3.5.1. Company Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Service Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. NextPharma
      • 8.3.6.1. Company Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Service Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Catalent Pharma Solutions
      • 8.3.7.1. Company Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Service Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. Thermo Fisher Scientific
      • 8.3.8.1. Company Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Service Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Lonza Group
      • 8.3.9.1. Company Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Service Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. The Lubrizol Corporation
      • 8.3.10.1. Company Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Service Benchmarking
      • 8.3.10.4. Strategic Initiatives
    • 8.3.11. SGS S.A.
      • 8.3.11.1. Company Overview
      • 8.3.11.2. Financial Performance
      • 8.3.11.3. Service Benchmarking
      • 8.3.11.4. Strategic Initiatives
    • 8.3.12. Bora Pharmaceutical CDMO
      • 8.3.12.1. Company Overview
      • 8.3.12.2. Financial Performance
      • 8.3.12.3. Service Benchmarking
      • 8.3.12.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 4 Global Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 5 Global Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 6 Global Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Region, 2018 - 2030 (USD Million)
  • Table 7 North America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 8 North America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 9 North America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 10 North America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 11 U.S. Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 12 U.S. Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 13 U.S. Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 14 Canada Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 15 Canada Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 16 Canada Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 17 Mexico Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 18 Mexico Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 19 Mexico Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 20 Europe Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 21 Europe Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 22 Europe Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 23 Europe Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 24 UK Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 25 UK Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 26 UK Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 27 Germany Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 28 Germany Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 29 Germany Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 30 France Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 31 France Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 32 France Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 33 Italy Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 34 Italy Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 35 Italy Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 36 Spain Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 37 Spain Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 38 Spain Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 39 Sweden Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 40 Sweden Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 41 Sweden Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 42 Denmark Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 43 Denmark Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 44 Denmark Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 45 Norway Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 46 Norway Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 47 Norway Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 52 Japan Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 53 Japan Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 54 Japan Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 55 China Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 56 China Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 57 China Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 58 India Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 59 India Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 60 India Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 61 Thailand Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 62 Thailand Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 63 Thailand Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 64 South Korea Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 65 South Korea Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 66 South Korea Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 67 Australia Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 68 Australia Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 69 Australia Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 70 Latin America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 71 Latin America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 72 Latin America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 73 Latin America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 74 Brazil Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 75 Brazil Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 76 Brazil Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 77 Argentina Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 78 Argentina Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 79 Argentina Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 84 South Africa Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 85 South Africa Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 86 South Africa Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 90 UAE Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 91 UAE Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 92 UAE Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2024 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2024 (USD Billion)
  • Fig. 16 Topical Drugs Contract Manufacturing Market dynamics
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Topical Drugs Contract Manufacturing Market: Product Type outlook and key takeaways
  • Fig. 20 Topical Drugs Contract Manufacturing Market: Product Type movement analysis
  • Fig. 21 Semi-solid Formulations Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Creams Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Ointments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Gel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Liquid Formulations Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Solid Formulations Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Transdermal Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Topical Drugs Contract Manufacturing Market: Scale of Operation outlook and key takeaways
  • Fig. 30 Topical Drugs Contract Manufacturing Market: Scale of Operation movement analysis
  • Fig. 31 Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Commercial Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Topical Drugs Contract Manufacturing Market: End Use outlook and key takeaways
  • Fig. 34 Topical Drugs Contract Manufacturing Market: End Use movement analysis
  • Fig. 35 Pharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Biopharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Regional Marketplace: Key Takeaways
  • Fig. 39 North America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 U.S. Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 Canada Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 Mexico Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Europe Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 UK Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Germany Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 France Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 Italy Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Spain Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Sweden Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Denmark Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Norway Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Asia Pacific Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Japan Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 China Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 India Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Thailand Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 South Korea Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Australia Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Latin America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Brazil Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Argentina Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 MEA Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 South Africa Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Saudi Arabia Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 UAE Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Kuwait Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Key company categorization
  • Fig. 91 Service heat map analysis
  • Fig. 92 Strategic framework